Global Non-invasive Intracranial Pressure Monitoring Device Market by Type (Optic Nerve Sheath Diameter, MRI/CT) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

The market for non-invasive intracranial pressure monitoring devices was worth USD 252.31million in 2019. It is projected to grow at a 6.3% compound annual growth rate (CAGR), between 2020 and 2027. Market growth is driven by the rising incidence of neurological disorders, and the increasing number of road accidents that result in traumatic brain injury, among other factors. The market is also being driven by rising demand for minimally invasive surgery, the introduction of new technologies and high demand for trauma care devices. Market growth is expected to be driven by the increasing number of neurological disorders such as intracranial tumours, hydrocephalus and brain infection, meningitis and brain infections, as well rising incidences of injuries and traumas due to road accidents and sports injuries.

According to the American Association for the Surgery of Trauma in 2017, 1.2 million people died worldwide. This is equivalent to approximately 3,242 deaths per hour due to road accidents. This trauma or injury results in an increase in intracranial pressure. This would lead to a positive impact on the market's growth. Meningitis, also known as brain infection, can cause intracranial pressure to rise. According to the WHO 2018, around 30,000 cases are reported each year in sub-Saharan Africa from meningitis. These devices monitor intracranial pressure continuously and enable neurosurgeons to quickly diagnose the disease and provide timely treatment. This positively impacts the market's growth.

This market is also driven by the growing demand for minimally invasive surgical methods due to improved patient outcomes. Alternative non-invasive methods have been developed to measure elevated ICP. They are less invasive, more expensive, and pose additional risks than standard ICP monitoring methods. Invasive techniques are not practical in all situations, including emergencies. This is because there aren't enough skilled professionals. These problems can be solved by non-invasive techniques such as transcranial Doppler Ultrasonography, optic nerve sheath diameter, and MRI/CT.

Vittamed 205, which was developed by Vittamed Corporation and Cerepress by Third Eye Diagnostics are both designed to monitor ICP non-invasively through the eyes. The MMS-14, developed by Marchbanks Measurement Systems, and the HS-1000M Monitor, developed by HeadSense Medical, Ltd., also use acoustic sounds to measure and monitor ICP without needing to be invasive through the ears. They are intended to be used in patients with stroke, traumatic brain injuries/concussions, hydrocephalus, neurological conditions, and other pathologies that may lead to intracranial hyper- and hypotension. These procedures have many benefits that contribute to market growth.

The development of ICP monitoring devices with advanced technology has made it possible to reduce human interference during surgical procedures. These devices have the potential to reduce some of the disadvantages of older invasive-type devices such as an impulsive shift at baseline pressure, leveling and de-bubbling associated with fluid-filled techniques. Recent innovations include high-definition microscopic camera, remote navigation systems and motion sensors. To develop technologically advanced devices, key market players have been involved in extensive research. Medtronic, for example, signed an agreement in November 2016 with University Hospitals. They will collaborate to improve the workflow and operational efficiency of various procedures including electrophysiology, catheterization, and others. This agreement is expected to increase market growth over the forecast period.

The United States and Canada have seen a high number of cases of trauma and neurological disorders. According to the 2020 report by the American Association for the Surgery of Trauma, trauma is the leading cause of death for people up to 45 years old in the United States. Market growth is also due to the technologically advanced healthcare infrastructure, and increased awareness among patients about the benefits of minimally invasive surgery. The demand for intracranial pressure monitoring devices will also increase due to an increase in road accidents. According to the Brain Injury Association of Waterloo–Wellington (BIAWW), more than 11,000 people are killed each year from brain injuries in Canada, while over 6,000 are permanently disabled. This will boost market growth during the forecast period.

The global geriatric population continues to grow at an alarming rate. The UN Department of Economic and Social Affairs reports that the current global population stands at 7.7 billion. This number is projected to rise to 9.7 billion in 2050. Geriatrics are more susceptible to neurological conditions and traumatic brain injuries. The market's growth will be driven by the growing geriatric population. The market growth is also expected to be boosted by the untapped opportunities presented by the high geriatric population of Asian countries like Japan and China. According to estimates, Japan's 65-year-old population is more than 20%. A WHO report states that falls-related injuries among the elderly in China are a significant health and social concern. It is estimated that between 18% and 44% of elderly suffer from these injuries.

Type Insights

The market can be divided into four types: transcranial Doppler Ultrasonography (TMD), tympanic Membran Displacement (TMD), optic Nerve Sheath Diameter (MRI/CT), and fundoscopy(papilledema) based on its type. With a market share of 28.34%, MRI/CT dominated the market in 2019. With a market share of 28.34% in 2019, MRI/CT was the dominant segment. These devices are fast and safe, easy to use, and produce excellent images with high contrast between normal and pathologic tissues. MRI/CT scans are also the most popular imaging device due to their greater sensitivity for assessing patients with traumatic brain injury with high ICPs. This segment has seen a rise in applications for the diagnosis and staging neurological diseases, as well as its benefits over other imaging modalities.

From 2020-2027, the optic nerve sheath segment with the largest diameter segment will experience the highest CAGR at 6.9%. This is because it is the most suitable and preferred mode of treatment for severe head trauma, intracranial hemorhage, and hydrocephalus. The segment is expected to be driven by increasing patient preference for noninvasive procedures and high physician preference.

Application Insights

The market can be divided by application into subarachnoid hemorhage and meningitis, traumatic brain injury, intracerebral bleeding, and others. With a 46.73% share in 2019, the traumatic brain injury segment was the dominant market. This is due to an increasing number of traumatic brain injuries caused by road accidents, falls and violence. According to the CDC the number of traumatic head injuries has increased significantly in recent years. Patients with traumatic brain injury are most likely to die from elevated ICP. Accurate assessment of ICP is crucial for the success of treatment. Non-invasive intracranial pressure monitor devices are used to maintain cerebral perfusion pressure within the normal range. This will fuel segment growth over the forecast period.

CNS infection and brain edema will be the most affected segments, with a CAGR of 7.0% between 2020-2027. According to the Hydrocephalus Society's 2018 report, approximately 1 million Americans suffer from hydrocephalus. It is the leading cause of ICP elevation. Brain edema can cause elevated intracranial pressure. This requires accurate measurement to ensure timely and effective treatment. A large portion of the world's population is affected by CNS infection, hydrocephalus or brain edema. ICP measurement is essential for prompt and safe treatment.

Regional Insights

North America was the dominant market player with 46.78% of the share in 2019. The market's dominant position was due to its high prevalence of neurological disorders and the increasing number of trauma cases. This leads to increased intracranial pressure. These factors will increase the use of non-invasive intracranial Pressure Monitoring Devices in the region, which is expected to positively impact the growth of this market. The market will grow due to supportive government initiatives such as the American Society of Craniofacial Surgery's (ASCFS) establishment of minimally invasive Craniomaxillofacial surgery (CMF), which are expected to boost growth over the forecast period. The market is being driven by the rising prevalence of neurological disorders as well as the growing awareness of minimally invasive surgery among people.

Asia Pacific will grow at 7.3% CAGR between 2020 and 2027. This is due to the large patient population in emerging economies like India and China as well as rising healthcare spending in this region. The market is also impacted by the high number of clinical trials, high R&D investments and low-cost services. The market is also growing due to the rising incidence of neurological diseases and road accidents. The WHO Global Report on Road Safety 2018 estimates that India accounts for around 11% road accident-related deaths worldwide. In 2018, there were 4,67,044 reported road accidents. Market growth is expected to be accelerated by this trend over the forecast period.

Market Share Insights & Key Companies

A large market share is held by key market players due to their extensive product range. Market leaders engage in extensive research to develop advanced technologies. Medtronic's StealthStation technology was launched at the AANS conference in Los Angeles in April 2017. This new model will replace the previous models and will improve neurosurgery workflow.

Many companies are also forming partnerships and collaborations to increase their product range, expand their reach, and offer more competitive differentiation. Medtronic, for USD 1.7billion, acquired Mazor Robotics, an Israeli-based robotic-assisted surgical platform. This acquisition will allow Mazor Robotics to integrate into Medtronic's Neurosurgery division and strengthen the company's position in spine surgery. In a similar vein, Integra LifeSciences purchased Arkis Biosciences Inc. in July 2019. This company is a manufacturer of neurosurgical devices. Integra will increase its product offering in neurocritical care with this acquisition. These initiatives will increase the company's revenues and global presence over the next few years. The following are some of the major players in global intracranial pressure monitoring devices market:

• Codman Neuro (Integra LifeSciences)

• Medtronic

• RAUMEDIC AG

• SOPHYSA

• Spiegelberg GmbH & Co. KG

• Natus Medical Incorporated

• Gaeltec Devices Ltd.

• Neural Analytics

Up Market Research published a new report titled “Non-invasive Intracranial Pressure Monitoring Device Market research report which is segmented by Type (Optic Nerve Sheath Diameter, MRI/CT), By Players/Companies Medtronic, Gaeltec Devices Ltd, SOPHYSA, RAUMEDIC AG, Spiegelberg GmbH & Co KG, Natus Medical Incorporated, Neural Analytics, Codman Neuro (Integra LifeSciences)”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Non-invasive Intracranial Pressure Monitoring Device Market Report Segments:

The market is segmented by Type (Optic Nerve Sheath Diameter, MRI/CT).

Non-invasive Intracranial Pressure Monitoring Device Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Non-invasive Intracranial Pressure Monitoring Device Market

Overview of the regional outlook of the Non-invasive Intracranial Pressure Monitoring Device Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Non-invasive Intracranial Pressure Monitoring Device Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Non-invasive Intracranial Pressure Monitoring Device Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Optic Nerve Sheath Diameter

                2. MRI/CT

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Non-invasive Intracranial Pressure Monitoring Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Non-invasive Intracranial Pressure Monitoring Device Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.